Embase

Embase is a biomedical and pharmacological database published by Elsevier. It contains indexed literature that is not readily available in other databases. Embase includes articles from journals that are not indexed by other biomedical sources, particularly those from Europe.

Overview

Embase was launched in 1974 by Excerpta Medica, a Dutch publishing company that was later acquired by Elsevier. The database contains over 32 million records from over 8,500 currently indexed journals. Embase's literature is primarily from 1947 to the present, with selected coverage from 1902.

Content

Embase covers the fields of drug development, clinical guidelines, treatment evaluation, drug safety, pharmacoeconomics, and pharmacoepidemiology. It also includes the fields of molecular biology, biotechnology, health policy management, public health, occupational health, environmental health, drug dependence and abuse, psychiatry, forensic science, and biomedical engineering.

Features

Embase provides access to the most recent and relevant medical literature with a strong focus on evidence-based medicine. It includes unique non-English content and literature from the most important types of evidence, such as systematic reviews, health technology assessments and controlled trials. Embase's comprehensive indexing process uses the Emtree controlled vocabulary, which is updated annually to ensure all records are indexed accurately.

Access

Access to Embase is generally provided through institutional subscriptions, such as those held by universities and medical schools. Some public libraries and other non-profit institutions also provide access. Individuals can purchase short-term access to Embase.

See also

• PubMed
• Web of Science
• Scopus

References

<references />

   This article is a medical stub. You can help WikiMD by expanding it!